Takeda Pharmaceutical Company Limited Takeda (NYSE: TAK) and Evotec Announces Multi-RNA target Alliance Takeda Pharmaceutical Company Limited (NYSE: TAK) has inked an agreement with Evotec SE. Both the firms have made a strategic partnership with the sole aim to discover and create RNA targeting small molecule therapeutics.
